235 related articles for article (PubMed ID: 11118121)
21. Simultaneous determination of lamivudine, lopinavir, ritonavir, and zidovudine concentration in plasma of HIV-infected patients by HPLC-MS/MS.
Notari S; Sergi M; Montesano C; Ivanovic J; Narciso P; Pucillo LP; Ascenzi P
IUBMB Life; 2012 May; 64(5):443-9. PubMed ID: 22473795
[TBL] [Abstract][Full Text] [Related]
22. Development of a direct assay for measuring intracellular AZT triphosphate in humans peripheral blood mononuclear cells.
Becher F; Schlemmer D; Pruvost A; Nevers MC; Goujard C; Jorajuria S; Guerreiro C; Brossette T; Lebeau L; Créminon C; Grassi J; Benech H
Anal Chem; 2002 Aug; 74(16):4220-7. PubMed ID: 12199596
[TBL] [Abstract][Full Text] [Related]
23. In vitro analysis of synergism and antagonism of different nucleoside/nucleotide analogue combinations on the inhibition of human immunodeficiency virus type 1 replication.
Perez-Olmeda M; Garcia-Perez J; Mateos E; Spijkers S; Ayerbe MC; Carcas A; Alcami J
J Med Virol; 2009 Feb; 81(2):211-6. PubMed ID: 19107982
[TBL] [Abstract][Full Text] [Related]
24. Zidovudine triphosphate and lamivudine triphosphate concentration-response relationships in HIV-infected persons.
Fletcher CV; Kawle SP; Kakuda TN; Anderson PL; Weller D; Bushman LR; Brundage RC; Remmel RP
AIDS; 2000 Sep; 14(14):2137-44. PubMed ID: 11061655
[TBL] [Abstract][Full Text] [Related]
25. High levels of zidovudine (AZT) and its intracellular phosphate metabolites in AZT- and AZT-lamivudine-treated newborns of human immunodeficiency virus-infected mothers.
Durand-Gasselin L; Pruvost A; Dehée A; Vaudre G; Tabone MD; Grassi J; Leverger G; Garbarg-Chenon A; Bénech H; Dollfus C
Antimicrob Agents Chemother; 2008 Jul; 52(7):2555-63. PubMed ID: 18426897
[TBL] [Abstract][Full Text] [Related]
26. Lack of evidence for in vivo transformation of zidovudine triphosphate to stavudine triphosphate in human immunodeficiency virus-infected patients.
Meléndez M; Blanco R; Delgado W; García R; Santana J; García H; Rosario O; Rodríguez JF
Antimicrob Agents Chemother; 2006 Mar; 50(3):835-40. PubMed ID: 16495240
[TBL] [Abstract][Full Text] [Related]
27. Development of a new cartridge radioimmunoassay for determination of intracellular levels of lamivudine triphosphate in the peripheral blood mononuclear cells of human immunodeficiency virus-infected patients.
Robbins BL; Tran TT; Pinkerton FH; Akeb F; Guedj R; Grassi J; Lancaster D; Fridland A
Antimicrob Agents Chemother; 1998 Oct; 42(10):2656-60. PubMed ID: 9756772
[TBL] [Abstract][Full Text] [Related]
28. Development of a pharmacodynamic model for HIV treatment with nucleoside reverse transcriptase and protease inhibitors.
Hurwitz SJ; Schinazi RF
Antiviral Res; 2002 Nov; 56(2):115-27. PubMed ID: 12367718
[TBL] [Abstract][Full Text] [Related]
29. A rapid and sensitive method for simultaneous determination of lamivudine and zidovudine in human serum by on-line solid-phase extraction coupled to liquid chromatography/tandem mass spectrometry detection.
Estrela Rde C; Salvadori MC; Suarez-Kurtz G
Rapid Commun Mass Spectrom; 2004; 18(10):1147-55. PubMed ID: 15150840
[TBL] [Abstract][Full Text] [Related]
30. Joint population pharmacokinetic analysis of zidovudine, lamivudine, and their active intracellular metabolites in HIV patients.
Bazzoli C; Bénech H; Rey E; Retout S; Salmon D; Duval X; Tréluyer JM; Mentré F;
Antimicrob Agents Chemother; 2011 Jul; 55(7):3423-31. PubMed ID: 21576446
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of purified recombinant reverse transcriptase from wild-type and zidovudine-resistant clinical isolates of human immunodeficiency virus type 1 by zidovudine, stavudine, and lamivudine triphosphates.
Duan C; Poticha D; Stoeckli TC; Petropoulos CJ; Whitcomb JM; McHenry CS; Kuritzkes DR
J Infect Dis; 2001 Nov; 184(10):1336-40. PubMed ID: 11679926
[TBL] [Abstract][Full Text] [Related]
32. Zidovudine phosphorylation in HIV-infected patients and seronegative volunteers.
Barry M; Wild M; Veal G; Back D; Breckenridge A; Fox R; Beeching N; Nye F; Carey P; Timmins D
AIDS; 1994 Aug; 8(8):F1-5. PubMed ID: 7986398
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous determination of the HIV nucleoside analogue reverse transcriptase inhibitors lamivudine, didanosine, stavudine, zidovudine and abacavir in human plasma by reversed phase high performance liquid chromatography.
Verweij-van Wissen CP; Aarnoutse RE; Burger DM
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):121-9. PubMed ID: 15664342
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous determination of zidovudine and lamivudine in human serum using HPLC with tandem mass spectrometry.
Kenney KB; Wring SA; Carr RM; Wells GN; Dunn JA
J Pharm Biomed Anal; 2000 Jul; 22(6):967-83. PubMed ID: 10857566
[TBL] [Abstract][Full Text] [Related]
35. Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV-infected individuals.
Anderson PL; Kakuda TN; Kawle S; Fletcher CV
AIDS; 2003 Oct; 17(15):2159-68. PubMed ID: 14523272
[TBL] [Abstract][Full Text] [Related]
36. High throughput LC-MS/MS method for simultaneous determination of zidovudine, lamivudine and nevirapine in human plasma.
Kumar VR; Reddy BP; Kumar BR; Sreekanth K; Babu KN
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar; 921-922():9-14. PubMed ID: 23416289
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of lamivudine and lamivudine-triphosphate after administration of 300 milligrams and 150 milligrams once daily to healthy volunteers: results of the ENCORE 2 study.
Else LJ; Jackson A; Puls R; Hill A; Fahey P; Lin E; Amara A; Siccardi M; Watson V; Tjia J; Emery S; Khoo S; Back DJ; Boffito M
Antimicrob Agents Chemother; 2012 Mar; 56(3):1427-33. PubMed ID: 22183172
[TBL] [Abstract][Full Text] [Related]
38. Long-term subcutaneous tissue changes among antiretroviral-naive persons initiating stavudine, zidovudine, or abacavir with lamivudine.
Shlay JC; Sharma S; Peng G; Gibert CL; Grunfeld C
J Acquir Immune Defic Syndr; 2008 May; 48(1):53-62. PubMed ID: 18491421
[TBL] [Abstract][Full Text] [Related]
39. Influence of prior exposure to zidovudine on stavudine phosphorylation in vivo and ex vivo.
Hoggard PG; Sales SD; Phiboonbanakit D; Lloyd J; Maher BA; Khoo SH; Wilkins E; Carey P; Hart CA; Back DJ
Antimicrob Agents Chemother; 2001 Feb; 45(2):577-82. PubMed ID: 11158757
[TBL] [Abstract][Full Text] [Related]
40. A phase II randomized study of the virologic and immunologic effect of zidovudine + stavudine versus stavudine alone and zidovudine + lamivudine in patients with >300 CD4 cells who were antiretroviral naive (ACTG 298).
Pollard RB; Tierney C; Havlir D; Tebas P; Fox L; Smeaton L; Richman D; Friedland GH
AIDS Res Hum Retroviruses; 2002 Jul; 18(10):699-704. PubMed ID: 12167276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
